New study aims to cut opioid use after surgery
NCT ID NCT06505187
Summary
This study is testing whether a combination of celecoxib (a non-opioid anti-inflammatory) and Tylenol can effectively manage pain after parotid gland surgery, potentially reducing the need for opioid painkillers. Researchers will compare this approach to a placebo in 84 adults undergoing this specific surgery. Participants will track their pain and medication use for 7 days after their operation to see if the non-opioid option works well enough to limit opioid prescriptions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROTIDECTOMY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53702, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.